169 related articles for article (PubMed ID: 32045726)
1. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas.
Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G
World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726
[TBL] [Abstract][Full Text] [Related]
2. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS
J Neurosurg; 2019 May; 133(1):79-88. PubMed ID: 31075771
[TBL] [Abstract][Full Text] [Related]
3. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
4. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
Widhalm G; Wolfsberger S; Minchev G; Woehrer A; Krssak M; Czech T; Prayer D; Asenbaum S; Hainfellner JA; Knosp E
Cancer; 2010 Mar; 116(6):1545-52. PubMed ID: 20108311
[TBL] [Abstract][Full Text] [Related]
6. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
[TBL] [Abstract][Full Text] [Related]
7. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
8. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.
Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S
PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718
[TBL] [Abstract][Full Text] [Related]
10. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
11. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.
Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF
J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971
[TBL] [Abstract][Full Text] [Related]
13. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
[TBL] [Abstract][Full Text] [Related]
14. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
Yordanova YN; Moritz-Gasser S; Duffau H
J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
[TBL] [Abstract][Full Text] [Related]
15. Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas?
Lima GL; Duffau H
J Neurosurg; 2015 Jun; 122(6):1397-405. PubMed ID: 25723301
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
17. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Hadjipanayis CG; Widhalm G; Stummer W
Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
[TBL] [Abstract][Full Text] [Related]
18. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
19. The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
Jaber M; Wölfer J; Ewelt C; Holling M; Hasselblatt M; Niederstadt T; Zoubi T; Weckesser M; Stummer W
Neurosurgery; 2016 Mar; 78(3):401-11; discussion 411. PubMed ID: 26366972
[TBL] [Abstract][Full Text] [Related]
20. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
Díez Valle R; Slof J; Galván J; Arza C; Romariz C; Vidal C;
Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
